These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnosis and management of heparin-induced thrombocytopenia. Kouides PA; Fricke W Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):335-45. PubMed ID: 15853606 [TBL] [Abstract][Full Text] [Related]
5. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis]. Gavranić BB; Basić-Jukić N; Kes P Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420 [TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy. Charif R; Davenport A Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883 [TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia in a uremic patient requiring hemodialysis: an alternative treatment and reexposure to heparin. Matsuo T; Kusano H; Wanaka K; Ishihara M; Oyama A Clin Appl Thromb Hemost; 2007 Apr; 13(2):182-7. PubMed ID: 17456628 [TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires. Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215 [TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia. Warkentin TE Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280 [TBL] [Abstract][Full Text] [Related]
11. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature]. Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252 [TBL] [Abstract][Full Text] [Related]
12. The approach to heparin-induced thrombocytopenia. Linkins LA; Warkentin TE Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088 [TBL] [Abstract][Full Text] [Related]
13. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis. Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278 [TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia in intensive care patients. Selleng K; Selleng S; Greinacher A Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282 [TBL] [Abstract][Full Text] [Related]
15. [The management of patients with heparin-induced thrombocytopenia]. Pötzsch B; Madlener K Hamostaseologie; 2006 Jan; 26(1):22-6. PubMed ID: 16444318 [TBL] [Abstract][Full Text] [Related]
17. Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure. Hein OV; von Heymann C; Morgera S; Konertz W; Ziemer S; Spies C Artif Organs; 2005 Jun; 29(6):507-10. PubMed ID: 15926989 [TBL] [Abstract][Full Text] [Related]
18. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229 [TBL] [Abstract][Full Text] [Related]